Tackling AMR in Canada:
It Takes A Village
25 November, 2022, 12:00 EST
Become familiar with the most recent surveillance data on antimicrobial resistance and use.
Understand the roles and responsibilities of the newly formed Antimicrobial Resistance Task Force of the Public Health Agency of Canada.
Review the strategic priorities of the AMR Task Force, and ongoing actions to prevent and mitigate AMR and improve appropriate AMU.
Dr. Don Sheppard
MD, FRCPC, FECMM, FAAM, FASCI, FCAHS.
Dr. Sheppard currently serves as the Executive Scientific Director of the Antimicrobial Resistance Task Force of the Public Health Agency of Canada. A clinician-scientist and professor in Medicine and Microbiology & Immunology at McGill University, he practices medical microbiology at the McGill University Health Centre.
Dr. Sheppard’s research interests focus on elucidating the mechanisms by which biofilm-forming microorganisms cause human disease and resist antimicrobial therapy in order to develop new therapeutics for these infections. He has published over 150 research papers and book chapters and has delivered over 200 invited lectures worldwide.
Dr. Sheppard has been the recipient of numerous awards including a Clinician-Scientist award from the Canadian Institutes of Health Research and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund. He is an elected fellow of the American Society of Clinical Investigation and the American Academy of Microbiology.